title: Low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of coronary artery disease.
abstract: BACKGROUND
  Serum low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) may be generated by oxidization in the serum of patients with coronary artery disease (CAD). We determine the utility of the serum apoAI-LDL level as a novel coronary risk factor.
  
  
  METHODS
  We measured serum apoAI-LDL in 473 consecutive patients who underwent diagnostic coronary angiography. Serum levels of apoAI-LDL were assayed by a newly developed ELISA.
  
  
  RESULTS
  The patients consisted of 84 with unstable angina (UA), 259 with stable CAD, and 130 without CAD (control). The serum level of apoAI-LDL was higher in CAD patients than in the control group (31.4 (22.1-41.4) microg/ml vs. 24.6 (18.4-29.2) microg/ml, respectively, p<0.001), as well as in patients with UA compared to those with stable CAD 44.5 (35.8-51.9) microg/ml vs. 27.1 (19.5-35.6) microg/ml, respectively, p<0.0001) (data are expressed as the median (25th-75th percentiles)). By logistic regression analysis, only apoAI-LDL was independent, being significantly able to predict CAD (odds ratio: 1.50, 95% CI: 1.23-1.82, p<0.001), and differentiate unstable angina (odds ratio: 1.80, 95% CI: 1.48-2.17, p<0.001) after controlling for classical risk factors.
  
  
  CONCLUSIONS
  The serum level of apoAI-LDL, a newly identified component of oxidized LDL, may be a more sensitive marker of CAD and acute coronary syndrome than CRP.
authors.affiliation: The Cardiovascular Institute, Tokyo, Japan.
authors.forename: Ken
authors.initials: K
authors.lastname: Ogasawara
authors.forename: Shinichi
authors.initials: S
authors.lastname: Mashiba
authors.forename: Hideki
authors.initials: H
authors.lastname: Hashimoto
authors.forename: Shiho
authors.initials: S
authors.lastname: Kojima
authors.forename: Shunsuke
authors.initials: S
authors.lastname: Matsuno
authors.forename: Motohiro
authors.initials: M
authors.lastname: Takeya
authors.forename: Kazuo
authors.initials: K
authors.lastname: Uchida
authors.forename: Junji
authors.initials: J
authors.lastname: Yajima
mesh_terms: D000368:Aged; D016632:Apolipoprotein A-I / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood*; D003324:Coronary Artery Disease / Q000097:blood*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged
chemical_list: D016632:Apolipoprotein A-I; D015415:Biomarkers; D008078:Cholesterol, LDL